Frend System COVID-19 Ag

FREND™ COVID-19 Ag is a fluorescence immunoassay (FIA) for use with the FREND™ system.
This product is designed by healthcare providers to detect the SARS-CoV-2 nucleocapsid protein directly in nasopharyngeal swab samples from individuals with direct suspicion of COVID-19.
 
A total of 109 clinical samples (34 positive and 75 negative) confirmed with RT-PCR were tested with the FREND™ COVID-19 Ag. It shows 94.12% PPA (Positive Percent Agreement) and 100.00% NPA (Negative Percent Agreement) as shown below.